Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000895421-26-000037·Evolent Health, Inc.
Schedule 13G ownership disclosure
Evolent Health Inc
Class A Common Stock · CUSIP: 30050B101
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Morgan Stanley
Shares: 9,097,808 · Class: 8.1%
- Morgan Stanley Capital Services LLC
Shares: 7,380,233 · Class: 6.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000895421-26-000037
- Form type
- SCHEDULE 13G/A
- Filer
- Evolent Health, Inc.
- CIK
- CIK 1628908
- Filed
- Feb 11, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership